He, A. Et Al. 2014. Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis. Joint ACTRIMS-ECTRIMS Meeting , (Massachusetts, United States Of America), 193.

He, A., Spelman, T., Jokubaitis, V., Lugaresi, A., Izquierdo, G., Trojano, M., ... Grammond, P.(2014). Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis . Joint ACTRIMS-ECTRIMS Meeting (pp.193). Massachusetts, United States Of America

He, A. Et Al. "Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis," Joint ACTRIMS-ECTRIMS Meeting, Massachusetts, United States Of America, 2014

He, A. Et Al. "Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis." Joint ACTRIMS-ECTRIMS Meeting , Massachusetts, United States Of America, pp.193, 2014

He, A. Et Al. (2014) . "Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis." Joint ACTRIMS-ECTRIMS Meeting , Massachusetts, United States Of America, p.193.

@conferencepaper{conferencepaper, author={A. He Et Al. }, title={Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis}, congress name={Joint ACTRIMS-ECTRIMS Meeting}, city={Massachusetts}, country={United States Of America}, year={2014}, pages={193} }